跳至主要内容
临床试验/NCT07174557
NCT07174557招募中不适用

Beyond the Clinic: Enhancing Depression Surveillance With a Digital Biomarker

Dartmouth-Hitchcock Medical Center4 个研究点 分布在 1 个国家目标入组 320 人开始时间: 2026年5月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
320
试验地点
4
主要终点
Monthly depression relapse

研究概览

简要总结

Researchers hope to see if the data smartphones collect continuously can be used to predict if patient's depression symptoms will return. They will do this by collecting data from patient's smartphones and comparing it to their depression symptoms. If this method is successful, researchers could develop a smartphone application to help healthcare providers better monitor patient's depression and intervene earlier if symptoms return.

详细描述

Study phase 1: The investigators expect that participants will be in this research study for six months. Participants will be asked to download an app on their smartphone. This app will collect data from the phone's sensors. Participants will also be asked to answer some questions about their mood each month.

Study phase 2: This phase of the study is randomized which means that in order to learn about the effect of the Smartphone App, half the people in this study will use it, and the other half will not. If participants decide to enroll into this research study, they will be assigned by chance to one of the following groups:

Group A: Participants will be asked to download a Smartphone App. This App will collect data from the phone's sensors.

Group B: Participants will have usual care. Both Groups: Participants will be asked to complete questionnaires about their mood each month.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (18 years or older)
  • Treated for depression within Dartmouth Health collaborative care model (CoCM) sites who are discharged from CoCM without depression (PHQ-9 < 10)
  • Have access to and ability to use a smartphone (Android version ≥ 6 or iOS version ≥ 11).

排除标准

  • Identified as high risk due to active suicidality, psychosis, or bipolar disorder - Discharged from CoCM with ongoing depressive symptoms (PhQ-9 > 10

研究组 & 干预措施

Phase 1: Sensing System Calibration (N = 120)

Experimental

We expect that participants will be in this research study for six months. Participants will be asked to download an app on their smartphone. This app will collect data from the phone's sensors. Participants will also be asked to answer some questions about their mood each month.

干预措施: MoodTriggers Application (Other)

Phase 2: Early warning system (n = 100)

Active Comparator

This study is randomized which means that in order to learn about the effect of the Smartphone App, half the people in this study will use it, and the other half will not. If participants decide to enroll into this research study, they may be assigned by chance to download a Smartphone App. This App will collect data from the phone's sensors. Participants will also be asked to complete questionnaires about their mood each month.

干预措施: MoodTriggers Application (Other)

Phase 2: Usual Care (n = 100)

No Intervention

This study is randomized which means that in order to learn about the effect of the Smartphone App, half the people in this study will use it, and the other half will not. If participants decide to enroll into this research study, they may be assigned by chance to have usual care. Participants will be asked to complete questionnaires about their mood each month.

结局指标

主要结局

Monthly depression relapse

时间窗: discharge, 6-months post-discharge

The 9-item Patient Health Questionnaire (PHQ-9), a validated self-reported depression questionnaire, will be used to detect monthly depression recurrence based on past-month MoodTriggers application data. The PHQ-9 scores range from 0-27, with higher scores reflecting higher depression symptom levels. The PHQ-9 will be used to detect monthly recurrence of Major Depressive Disorder (MDD; PHQ-9 scores ≥ 10) during Phase 1 in all 120 participants. For the randomized clinical trial in Phase 2, we will capture the PHQ-9 monthly in both arms (MoodTriggers app vs. no app) for 6-months following discharge.

次要结局

  • Perceived benefits and barriers of depression monitoring using passive sensing data collected from mobile phones(0-6 months post-discharge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nicholas C. Jacobson

Principal Investigator

Dartmouth-Hitchcock Medical Center

研究点 (4)

Loading locations...

相似试验